ArticleScientific reports2025
A hybrid compound scaling hypergraph neural network for robust cervical cancer subtype classification using whole slide cytology images.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Benchmarking hybrid CNN and transformer backbones with graph convolution networks (GCN) for flower growth-stage classification.Scientific reports · 2026Article
- Recent advancements in the application of artificial intelligence-based approaches for screening, diagnosis, prognosis and treatment of cervical cancer.Oncology reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer is a major cause of mortality among women, particularly in low-income countries with insufficient screening programs. Manual cytological examination is time-consuming, error-prone and subject to inter-observer variability. Automated and robust classification of the whole slide cytology images for cervical cancer is essential for detecting precancerous and malignant lesions. We propose a novel deep learning framework, the Compound Scaling Hypergraph Neural Network model (CSHG-CervixNet), for robust classification of cervical cancer subtypes. The model integrates a Compound Scaling Convolutional Neural Network (CSCNN) with a k-dimensional Hypergraph Neural Network (kd-HGNN) architecture. CSCNN balances the network's depth, width, and resolution, supporting effective feature representation with minimal computational overhead. kd-HGNN captures higher-order relationships between the features, and its propagation mechanism ensures better feature diffusion across distant nodes. The model is evaluated on the benchmark Sipakmed dataset and achieves an accuracy of 99.31%, with a macro-averaged precision of 98.97%, recall of 99.38%, and F1-score of 99.34%, demonstrating its robustness in cervical cancer subtype classification. Pathologists and other medical experts will find this study helpful in distinguishing cervical cancer subtypes so that targeted treatment may be provided and effective disease management is made possible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.